MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jstrokecerebrovasdis.2025.108319

Медицинская библиотека · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2025

The annual economic burden of patent foramen ovale-associated stroke in the United States.

Volpi John J, Kasner Scott E, Neervoort Jet, Wolters Lambertus F, Louwsma Timon, Marti Anne K, Landaas Erik J

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Stroke is the second leading cause of death worldwide and the third leading cause of death and disability combined. Among ischemic strokes, 25 % to 40 % are classified as cryptogenic, with patent foramen ovale (PFO) identified as a potential underlying cause. PFO is found in 25 % of the general population. Despite the significant occurrence of PFO-associated strokes, the associated costs remain largely unexplored.

AIM: This study aimed to evaluate the annual economic burden of PFO-associated stroke in the US.

METHODS

A cost-of-illness study was performed, encompassing the direct and indirect costs of PFO-associated stroke on both society and the healthcare system. The model adopted a top-down approach and a one-year, US societal perspective. A payer perspective and bottom-up costing approach were included as scenario analyses. Data was obtained by a targeted literature review.

RESULTS

The societal model, assuming 32.5 % cryptogenic strokes, incurs an annual cost of over $1.3 billion in the US, with over $1.0 billion coming from new strokes and over $300 million from recurrent strokes. The majority of the costs are indirect-50 % from productivity losses due to premature death and 27 % from other productivity losses. Direct costs constitute 23 % of the total. From the payer perspective, the annual costs for PFO-associated strokes in the US were estimated at $302 million, with hospitalization costs comprising 44 %, followed by prescriptions and outpatient care at 19 % and 16 %, respectively.

CONCLUSION

The economic burden of PFO-associated strokes in the US is substantial, exceeding $1.3 billion per year. Different types of medical management or surgical treatments for PFO-associated stroke could lead to gains in both costs and health outcomes.

Для цитирования: Volpi John J, Kasner Scott E, Neervoort Jet, Wolters Lambertus F, Louwsma Timon, Marti Anne K, Landaas Erik J. The annual economic burden of patent foramen ovale-associated stroke in the United States.. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2025. DOI: 10.1016/j.jstrokecerebrovasdis.2025.108319.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.